Atlas Trials

Evaluation of "Dose-dense Therapy" by S-HAM in Comparison to Conventionally Timed Double Induction in Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT01382147 · COMPLETED

Trial details

NCT number
NCT01382147
Sponsor
Prof. Dr. Wolfgang Hiddemann
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2009-07-01
Primary completion
2012-08-01
Enrollment
396

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.